Press Releases
Keyword Search
10.29.19
OpGen Announces Date of Third Quarter 2019 Financial Results Conference Call
10.28.19
OpGen Announces Closing of $9.4 Million Underwritten Public Offering
10.23.19
OpGen Announces Pricing of $9.4 Million Underwritten Offering
10.23.19
U.S. Patent Allowed Covering Acuitas Lighthouse® Software
10.07.19
OpGen Presents Preliminary Acuitas® AMR Gene Panel Data for Detecting Urinary Tract Infections
09.26.19
OpGen to Present on Guiding Precision Antibiotic Therapy with Rapid Genomics and Informatics at IDWeek 2019
09.18.19
OpGen Provides update on Curetis Group’s R&D Collaboration
09.04.19
Curetis and OpGen Enter Into Definitive Agreement to Combine Businesses
08.07.19
OpGen Reports Second Quarter 2019 Financial Results and Provides Business Update
07.30.19
OpGen Announces Date of Second Quarter 2019 Financial Results Conference Call